Pyc Therapeutics Ltd has released a press release.
Response to ASX Query
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- Operational Update June quarter
- CEO and CSO Appointments
- Operational Update March Quarter
- Response to ASX Price Query
- Genentech extends research collaboration period
Later from PYC Therapeutics
- Appendix 4E - Preliminary Final Report 30 June 2017
- New Delivery Vehicles Show Improved Performance Inside Cells
- PYC Granted US Patent for Peptides Entering Brain Cells
- Quarterly Update and Appendix 4C
- Phylogica Strategic Update - Pivot to Platform
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics